iMD Companies, Inc. (OTC: ICBU) announced today that it has entered into advanced due diligence on two potential acquisition targets, one in the cryptocurrency infrastructure sector and the other in the medical technology space. Both opportunities align with the company's strategic focus on identifying and investing in high-growth industries supported by scalable technologies and long-term market demand.
According to the company, these potential acquisitions could strengthen its position across emerging sectors and support future revenue expansion. 'We are encouraged by the progress we’ve made in evaluating these opportunities,' said Richard Wilson, CEO of iMD Companies, Inc. 'Our approach remains disciplined and focused on identifying assets that can deliver sustainable growth and long-term value for our shareholders.'
The due diligence process is ongoing, with completion anticipated in the coming weeks. iMD Companies will provide updates as appropriate as evaluations progress. The company remains committed to maintaining transparency with its shareholders and will continue to communicate material developments in a timely manner.
For more information on iMD Companies, visit imdcompaniesinc.com or OTC Markets. Follow @imd_inc on X for real-time updates.
The announcement signals iMD's continued push into cryptocurrency and medical technology, sectors that have seen significant investor interest. The cryptocurrency infrastructure target, in particular, reflects the growing demand for scalable blockchain solutions, while the medical technology acquisition aligns with trends in digital health and medical device innovation.
Forward-looking statements in the press release caution that actual results may differ materially from projections due to various risks and uncertainties. The company does not undertake any obligation to update forward-looking statements.
